Jason Bacharach

3 weeks ago | ophthalmologytimes.com | Marguerite B. McDonald |Jason Bacharach |Sydney M Crago

Dry eye disease is one of the most common conditions that affect patients of all ages and demographics. For ophthalmologists, understanding the treatment options that can best meet the needs of their patients is important to helping those patients find relief from their dry eye symptoms. Among the treatment options is perfluorohexylactane eye drops. At the American Society of Cataract and Refractive Surgery 2025 annual meeting, Marguerite B.

1 month ago | ophthalmologytimes.com | Jason Bacharach |Sheryl Stevenson |Hattie Hayes

Perfluorohexylactane may offer a fast-acting option for dry eye symptom relief, showing measurable benefits within minutes of application, explained Jason Bacharach, MD, who presented findings on the agent’s early efficacy at the 2025 American Society of Cataract and Refractive meeting, held April 25 to 28 in Los Angeles, California.

Feb 27, 2025 | healio.com | Jason Bacharach |Anthony DeFino |Christine Klimanskis

Update email addressThe email address associated with your Healio account is:If you would like to edit or change the email address that your subscriptions and alerts are sent to, use the "Update email address" link. Update email address